hepat
defin
inflammatori
cell
infiltr
within
hepat
parenchyma
term
cholangiohepat
describ
extens
inflamm
includ
intrahepat
bile
duct
diagnosi
condit
base
histopatholog
examin
hepat
biopsi
specimen
histopatholog
appear
give
clue
durat
inflamm
acut
hepat
character
combin
inflamm
hepatocellular
apoptosi
necrosi
possibl
regener
lack
fibrosi
chronic
hepat
ch
hand
identifi
presenc
fibrosi
prolifer
ductular
structur
regen
nodul
addit
inflammatori
infiltr
type
inflammatori
cellular
infiltr
may
give
clinician
clue
regard
etiolog
occasion
etiolog
agent
identifi
within
biopsi
specimen
howev
etiolog
remain
unknown
mani
case
hepat
cholangiohepat
dog
cat
chapter
discuss
clinic
present
anim
hepat
cholangiohepat
outlin
commonli
recogn
clinic
syndrom
respect
diagnosi
treatment
specif
diseas
effect
treatment
patient
hepat
cholangiohepat
includ
specif
therapi
identifi
incit
caus
aggress
symptomat
support
therapi
discuss
symptomat
treatment
support
therapi
sequela
hepat
cholangiohepat
found
chapter
hepat
failur
gener
histor
find
associ
hepat
nonspecif
type
liver
diseas
exposur
certain
etiolog
agent
toxin
may
ascertain
owner
histori
thu
rais
suspicion
hepat
involv
import
rememb
larg
reserv
capac
liver
short
durat
clinic
sign
necessarili
indic
acut
diseas
anim
ch
may
show
outward
clinic
sign
signific
portion
hepat
function
affect
present
owner
complaint
anim
hepat
may
includ
vomit
diarrhea
anorexia
lethargi
polyuria
polydipsia
abdomin
distent
dysuria
neurolog
abnorm
associ
hepat
encephalopathi
vascular
accid
icteru
similar
histor
find
physic
examin
find
anim
hepat
often
nonspecif
icteru
present
absenc
hemolyt
anemia
suggest
diseas
hepat
parenchyma
extrahepat
biliari
system
anim
acut
hepat
like
fever
abdomin
pain
ch
like
ascit
hepatomegali
may
present
patient
especi
acut
hepat
mani
anim
hepat
physic
abnorm
present
initi
examin
serum
biochem
chang
case
like
direct
clinician
toward
liver
site
diseas
pathogenesi
wherebi
hepat
cholangiohepat
lead
hepatocellular
necrosi
apoptosi
incomplet
understood
experiment
studi
suggest
mani
mechan
hepatocellular
injuri
specif
evalu
dog
cat
hepat
lack
mechan
hepatocellular
injuri
specif
hepat
includ
tissu
hypoxia
lipid
peroxid
intracellular
cofactor
deplet
intracellular
toxin
product
cholestat
injuri
endotox
insult
hepatocyt
plasma
membran
injuri
hepatocyt
especi
suscept
anoxia
liver
receiv
mixtur
venou
arteri
blood
hypox
damag
quickli
lead
plasma
membran
cytosol
organel
injuri
secondari
adenosin
triphosph
atp
deplet
free
radic
may
caus
oxid
cellular
injuri
result
lipid
peroxid
subsequ
plasma
membran
damag
cellular
toxin
may
bind
nucleic
acid
inhibit
protein
synthesi
cholestasi
caus
retent
bile
acid
chapter
hepat
cholangiohepat
directli
damag
cellular
organel
endotoxin
work
via
variou
mechan
involv
stimul
inflammatori
cell
produc
inflammatori
mediat
cytokin
prostaglandin
leukotrien
perpetu
hepat
experiment
work
mous
model
suggest
import
role
tumor
necrosi
factoralpha
tnfa
initi
perpetu
hepat
tnfa
product
induc
interact
costimulatori
molecul
cell
hepatocyt
kupffer
cell
stimul
hepatocyt
apoptosi
fasfa
ligand
pathway
better
understand
complex
mechan
hepatocellular
injuri
anim
hepat
may
encourag
develop
novel
therapeut
modal
affect
patient
box
list
report
caus
hepat
cholangiohepat
dog
cat
complet
discuss
diseas
entiti
beyond
scope
chapter
discuss
common
clinic
syndrom
follow
felin
cholangitischolangiohepat
complex
one
common
hepatobiliari
disord
cat
syndrom
report
dog
primarili
felin
diseas
sever
classif
scheme
propos
defin
variou
element
syndrom
recent
world
small
anim
veterinari
associ
wsava
liver
standard
group
propos
classif
system
divid
felin
inflammatori
liver
diseas
two
main
categori
neutrophil
cholang
lymphocyt
cholang
neutrophil
cholang
nc
character
infiltr
neutrophil
within
wall
lumen
intrahepat
bile
duct
diseas
seen
acut
chronic
stage
acut
stage
edema
neutrophil
inflamm
may
extend
portal
area
chronic
stage
mix
inflammatori
infiltr
may
note
portal
area
along
vari
degre
fibrosi
bile
duct
hyperplasia
syndrom
previous
refer
acut
cholangiohepat
suppur
cholangitischolangiohepat
extrapol
data
use
classif
scheme
like
affect
cat
young
middleag
male
predisposit
durat
ill
usual
short
day
anorexia
weight
loss
lethargi
vomit
common
mani
cat
febril
anim
elev
serum
alanin
aminotransferas
alt
activ
time
present
fewer
number
elev
alkalin
phosphatas
alp
activ
icteru
present
case
cholangiohepat
cat
associ
inflammatori
bowel
diseas
ibd
pancreat
mani
investig
believ
nc
result
ascend
bacteri
infect
gastrointestin
gi
tract
howev
bacteri
organ
isol
inconsist
case
report
literatur
isol
common
bacteri
speci
includ
escherichia
coli
enterococcu
spp
clostridium
spp
bacteroid
spp
actinomyc
spp
streptococcu
spp
hepat
tissu
bile
submit
aerob
anaerob
cultur
part
diagnost
workup
cat
suspect
hepat
treatment
broadspectrum
antibiot
combin
aim
enter
flora
recommend
pend
result
cultur
sensit
test
prognosi
cat
nc
typic
good
aggress
treatment
although
sequela
may
includ
bile
duct
obstruct
acut
necrot
pancreat
sepsi
multipl
organ
dysfunct
lymphocyt
cholang
lc
chronic
form
diseas
character
mix
inflammatori
infiltr
typic
small
lymphocyt
lymphocyt
plasma
cell
within
portal
area
associ
sign
chronic
includ
bile
duct
prolifer
bridg
fibrosi
pseudolobul
format
inflamm
within
wall
lumen
intrahepat
bile
duct
may
present
specif
hallmark
diseas
lc
probabl
includ
wide
spectrum
clinic
diseas
vari
sever
clinic
signific
lc
like
includ
syndrom
previous
refer
chronic
cholangiohepat
nonsuppur
cholangitischolangiohepat
lymphocyt
portal
hepat
extrapol
data
use
classif
scheme
seem
cat
lc
tend
older
nc
clinic
sign
similar
seen
nc
except
fever
uncommon
onset
ill
insidi
durat
ill
tend
longer
cat
lc
elev
serum
alt
alp
total
bilirubin
common
nc
cat
lc
tend
higher
alp
nc
etiolog
lc
unknown
although
chronic
respons
ascend
bacteri
infect
gi
flora
associ
ibd
pancreat
seen
nc
suggest
activ
infect
rare
document
cat
lc
treatment
typic
involv
immunosuppress
glucocorticoid
therapi
anim
evid
infect
treatment
ursodeoxychol
acid
mgkg
po
anecdot
theoret
benefit
although
clinic
studi
examin
efficaci
cat
publish
prognosi
typic
good
appropri
manag
although
mani
caus
chronic
hepat
inflamm
dog
identifi
term
chronic
hepat
ch
describ
progress
necroinflammatori
diseas
unknown
etiolog
common
canin
popul
evid
support
immunemedi
process
perpetu
factor
although
unclear
whether
diseas
autoimmun
natur
outsid
insult
incit
immun
respons
chronic
natur
diseas
larg
reserv
capac
liver
mani
affect
anim
identifi
onset
fulmin
hepat
failur
howev
increas
number
case
identifi
earlier
asymptomat
stage
result
elev
hepat
enzym
activ
note
routin
serum
biochem
screen
anim
age
sex
affect
although
middleag
femal
dog
may
overrepres
ch
seen
increas
frequenc
certain
breed
box
suggest
famili
predisposit
specif
diagnost
find
separ
ch
caus
hepat
ultim
diagnosi
base
histopatholog
examin
liver
tissu
reveal
inflamm
usual
lymphocyt
plasmacyt
piecem
bridg
necrosi
possibl
fibrosi
andor
hyperplasia
ductular
structur
absenc
identifi
underli
caus
optim
treatment
protocol
anim
ch
well
studi
immunosuppress
therapi
mainstay
treatment
corticosteroid
class
drug
shown
potenti
provid
benefit
use
indic
patient
sign
hepat
failur
immunomodulatori
drug
may
use
includ
ursodeoxychol
acid
metronidazol
azathioprin
cyclosporin
copper
chelat
may
benefici
copper
retent
signific
contribut
factor
overal
prognosi
difficult
ascertain
asymptomat
anim
may
slowli
progress
cours
excel
prognosi
howev
hepat
failur
cirrhosi
develop
prognosi
poor
role
copper
pathogenesi
ch
unclear
elev
hepat
copper
level
identifi
mani
dog
ch
biliari
excret
major
mechan
maintain
copper
homeostasi
caus
cholestasi
would
expect
increas
hepat
copper
level
howev
shown
bedlington
terrier
elev
copper
level
caus
inherit
defect
excret
lead
ch
cirrhosi
howev
may
difficult
determin
came
first
copper
accumul
hepat
propens
increas
hepat
copper
level
associ
ch
describ
mani
breed
addit
bedlington
terrier
list
box
suspect
primari
hepat
copper
storag
disord
also
report
one
cat
whether
copper
accumul
primari
secondari
event
possibl
excess
copper
damag
hepatocyt
copper
chelat
treatment
improv
resolv
hepat
patholog
find
group
doberman
pinscher
elev
hepat
copper
level
subclin
ch
recommend
hepat
tissu
harbor
copper
quantif
dog
undergo
liver
biopsi
elev
level
identifi
reduct
dietari
copper
chelat
dpenicillamin
mgkg
given
hour
feed
trientin
mgkg
given
hour
feed
like
benefici
nonspecif
reactiv
hepat
histolog
diagnosi
describ
liver
respons
varieti
extrahepat
diseas
process
lesion
character
widespread
inflammatori
infiltr
usual
lymphocyt
plasma
cell
portal
area
parenchyma
absenc
hepatocellular
necrosi
identif
lesion
alert
clinician
liverspecif
problem
unlik
investig
underli
diseas
process
necessari
viral
hepat
uncommon
dog
cat
viral
infect
carri
poor
prognosi
specif
therapi
avail
evalu
symptomat
therapi
support
care
therefor
primari
therapeut
option
infecti
canin
hepat
caus
canin
adenoviru
type
diseas
becom
quit
rare
owe
extens
vaccin
protocol
use
crossreact
adenoviru
type
ii
diseas
seen
young
unvaccin
dog
degre
antibodi
respons
determin
sever
diseas
poor
respons
result
acut
fatal
syndrom
anim
mount
appropri
respons
may
recov
develop
ch
corneal
edema
anterior
uveiti
may
develop
anim
recov
acut
ill
diagnosi
made
histopatholog
identif
larg
basophil
amphophil
intranuclear
inclus
bodi
within
hepatocyt
kupffer
cell
identifi
first
week
infect
histopatholog
also
reveal
multifoc
coagul
necrosi
neutrophil
inflammatori
infiltr
may
present
anim
sever
acut
infect
felin
infecti
periton
fip
caus
felin
enter
coronaviru
fip
affect
organ
bodi
cat
hepat
involv
often
elev
activ
alt
aspart
aminotransferas
ast
develop
hyperbilirubinemia
diseas
progress
histolog
lesion
includ
multifoc
necrosi
often
around
blood
vessel
associ
infiltr
neutrophil
macrophag
pyogranulomat
lesion
may
note
liver
capsul
hepat
involv
occur
diseas
uniformli
fatal
definit
treatment
support
care
mainstay
treatment
although
cat
gener
resist
leptospirosi
experiment
infect
l
pomona
caus
hepat
lesion
speci
patient
hepat
involv
show
elev
level
hepat
enzym
alt
ast
alp
although
alp
often
sever
affect
hyperbilirubinemia
sign
hepat
failur
may
occur
diagnosi
leptospirosi
usual
base
clinic
suspicion
due
renal
hepat
involv
combin
serolog
evid
infect
howev
antibodi
titer
may
neg
first
week
infect
antibodi
product
may
persist
week
suspect
patient
neg
antibodi
titer
short
durat
ill
treat
though
leptospirosi
antibodi
titer
repeat
week
histopatholog
chang
liver
affect
anim
may
includ
coagul
necrosi
infiltr
lymphocyt
plasma
cell
lesser
number
neutrophil
macrophag
organ
may
identifi
biopsi
specimen
silver
stain
insensit
molecular
techniqu
polymeras
chain
reaction
pcr
like
make
diagnosi
less
challeng
futur
optim
treatment
includ
penicillin
elimin
leptospirem
stage
follow
doxycyclin
enrofloxacin
elimin
carrier
state
note
use
enrofloxacin
dog
toler
doxycyclin
well
studi
prognosi
typic
good
patient
often
requir
intens
support
care
includ
hemodialysi
anim
oligur
anur
renal
failur
bartonella
hensela
bartonella
clarridgeia
identifi
caus
hepat
diseas
dog
arthropodtransmit
bacteria
etiolog
agent
catscratch
diseas
human
isol
approxim
healthi
cat
clinic
find
similar
dog
caus
hepat
histolog
examin
hepat
tissu
dog
b
hensela
infect
reveal
peliosi
hepati
granulomat
hepat
describ
infect
human
diagnosi
made
via
identif
bartonella
dna
use
pcr
techniqu
hepat
biopsi
specimen
prefer
method
diagnosi
serolog
assay
impart
inform
regard
exposur
granulomat
hepat
may
caus
agent
caus
granulomat
hepat
dog
frequent
unknown
although
report
caus
includ
fungal
infect
mycobacteri
infect
dirofilariasi
lymphoma
histiocytosi
intestin
lymphangiectasia
azithromycin
antibiot
choic
treatment
bartonellosi
although
use
dog
hepat
diseas
caus
bartonella
spp
thoroughli
evalu
import
caus
hepat
critic
ill
dog
cat
bacteri
seed
liver
secondari
bacteremia
via
transloc
gi
tract
commonli
isol
aerob
bacteria
includ
staphylococcu
spp
streptococcu
spp
enter
gramneg
organ
commonli
identifi
anaerob
includ
bacteroid
spp
clostridium
spp
fusobacterium
spp
diagnosi
bacteremia
difficult
veterinari
patient
septicemiainduc
hepat
suspect
critic
ill
anim
develop
clinicopatholog
evid
hepat
diseas
hospit
especi
bacteri
infect
sever
gi
diseas
document
treatment
broadspectrum
antimicrobi
pend
sensit
test
along
aggress
support
care
vital
success
outcom
main
histolog
lesion
associ
toxic
hepat
injuri
diffus
centrilobular
necrosi
depend
tempor
relationship
toxin
ingest
tissu
biopsi
necrosi
may
accompani
apoptosi
inflamm
lymphocyt
plasmacyt
cellular
infiltr
may
occur
later
cours
diseas
describ
commonli
amiodaron
carprofen
lomustin
intox
phenobarbit
primidon
phenytoin
may
caus
ch
progress
cirrhosi
prolong
use
sever
drug
report
caus
hepat
note
box
mean
exhaust
list
treatment
involv
remov
offend
agent
aggress
support
care
sadenosylmethionin
mgkg
po
effect
treat
acetaminophen
toxic
although
efficaci
form
hepatotox
evalu
logic
choic
support
care
anim
suffer
hepatotox
insult
mainli
abil
increas
hepat
glutathion
level
